AstraZeneta's clinical restart of the vaccine, Goforth, said a single event would not hinder vaccine development.

AstraZeneta's new crown vaccine is considered one of the most promising in the world.
experts say this single negative event will not affect the process of developing vaccines around the world.
, but some researchers believe AstraZeneta should win public trust by publishing the results of its findings on adverse reactions in vaccinators.
AstraZeneta revealed on Friday that a woman in the UK who had been vaccinated against the company's new coronary vaccine had developed symptoms similar to rare and severe spinal inflammation, a condition known as transverse spinal corditis, a neurological condition.
" more tests are under way and a final diagnosis is still pending.
," AstraZeneta said in a statement.
, however, when it announced the restart of clinical trials on Saturday, AstraZenecom did not disclose an assessment of the link between the occurrence of this unexplained and serious neurological disease and vaccination.
university said in a statement that it was unable to disclose information about vaccine participants because of the protection of the privacy of vaccinators.
is currently conducting clinical Phase III trials of the new crown vaccine in several countries around the world, and the company's global trial of the new crown vaccine has been suspended following adverse reactions.
whether regulators in the US, India, Brazil and other countries will also let go after UK regulators gave AstraZeneta a "green light" again.
, director of the China Center for Disease Control and Prevention, told First Financial News: "If this is a single event, then once processed, clinical trials can be restarted immediately."
" "AstraZeneta's vaccine clinical suspension to restart reflects the importance of processes and norms in vaccine development, must be tested in accordance with the regulations."
," a researcher who has been studying the Ebola virus for a long time told First Financial.
he said AstraZene should disclose the findings of the investigation if it wanted to win public confidence.
"find out what the relationship between sick patients and clinical trials of vaccines is the most important thing at the moment."
," he told First Financial.
, which operates routinely, says the suspension of clinical trials of vaccines is voluntary and, in fact, a routine measure.
industry practice, in clinical trials, routine suspensions are required to ensure the integrity of clinical trials of vaccines in the event of a potentially unsealable disease.
Paul Duprex, director of the Vaccine Research Center at the University of Pittsburgh, said: "Review does not necessarily mean that candidate vaccines are unsafe, but when vaccine development presses the 'fast-forward button', it is necessary to investigate adverse reactions in clinical trials.
," he added, adding that pharmaceutical companies would be very cautious about clinical trials because the new crown vaccine would be available on a large scale.
AstraZeneta currently plans to bring in nearly 60,000 clinical trials worldwide and has reached agreements with governments to provide a total of nearly 3 billion doses of the vaccine, more than any other vaccine.
this is not the first time AstraZeneta's new crown vaccine has experienced a clinical trial suspension.
AstraZeneca CEO Pascal Soriot said in a phone call with investors on Wednesday that a vaccinator had been found to have neurological symptoms as early as July and was later diagnosed with multiple sclerosis, which AstraZeneca suspended after an independent review panel concluded that multiple sclerosis had nothing to do with vaccination.
that a scientific approach to vaccines in clinical trials actually inspires confidence in science and vaccine research and development.
Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and an infectious disease expert, called AstraZenecom's decision to suspend clinical trials of vaccines a "safety valve" and WHO said the suspension of clinical trials of AstraZeneta's vaccines was a "wake-up call" for the world.
Tuesday, nine pharmaceutical companies, including AstraZenecom, issued a "safety commitment" to vaccine research and development.
statement, the nine companies pledged to "stand on a scientific stand" and reiterated that they would develop and test potential new crown vaccines "in accordance with high ethical standards and reasonable scientific principles."
.